Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida species are the fourth most common cause of hospital-acquired bloodstream infections (BSI) in the United States (5, 9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
In the citing paper
“These species proportions are very similar to those previously reported from the northeastern United States (9).”
In the citing paper
“The National Epidemiology of Mycoses Survey study demonstrated geographic variations in species distributions throughout the United States, with C. albicans ranging from 46% in the northeast to 70% in the southwest and C. glabrata ranging from 15% in the southwest to 26% in the northeast (9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 3×
“Nonetheless, prospective surveillance projects such as ours will allow rapid detection of such infections, which initially appeared in Japan [17, 18] and have been reported in the United States [19].”
BackgroundHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 1×
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationPfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331
Self-citationCeftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationMarshall, S. A., Wilke, W. W., Pfaller, M. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00212-5 · Cited by 146
Self-citationAntimicrobial Resistance: Issues and Options
(1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 129
Cited by
Items 101–200 of 1,001
Healy, C. M., Hulten, K. G., Palazzi, D. L., Campbell, J. R., & Baker, C. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425321 · Cited by 229
Pappas, P. G. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.004 · Cited by 227
Stage‐specific gene expression of Candida albicans in human blood
Fradin, C., Kretschmar, M., Nichterlein, T., Gaillardin, C., D’Enfert, C., & Hube, B. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03396.x · Cited by 226
“Bloodstream infections caused by fungi have increased dramatically in the last 10 years, and C. albicans remains the primary pathogenic fungus in most types of systemic fungal infections (Edmond et al., 1999; Harbarth et al., 1999; Pfaller et al., 2000).”
BackgroundTrends in the Epidemiology of Invasive Fungal Infections
Warnock, D. W. (2007) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.48.1 · Cited by 226
Extended‐Spectrum β‐Lactamases: Epidemiology, Detection, and Treatment
Nathisuwan, S., Burgess, D. S., & Lewis, J. S. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.11.920.34529 · Cited by 226
Bougnoux, M.-E., Kac, G., Aegerter, P., d’Enfert, C., Fagon, J.-Y., & CandiRea Study Group (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0865-y · Cited by 224
Coevolution of Morphology and Virulence in Candida Species
Thompson, D. S., Carlisle, P. L., & Kadosh, D. (2011) · Eukaryotic Cell · doi:10.1128/ec.05085-11 · Cited by 224
Chow, J. K., Golan, Y., Ruthazer, R., Karchmer, A. W., Carmeli, Y., Lichtenberg, D., Chawla, V., Young, J., & Hadley, S. (2008) · Clinical Infectious Diseases · doi:10.1086/529435 · Cited by 223
Bacteremias: A Leading Cause of Death
Bearman, G. M. L., & Wenzel, R. P. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.02.005 · Cited by 220
Self-citationCandida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway
Fu, Y., Ibrahim, A. S., Sheppard, D. C., Chen, Y., French, S. W., Cutler, J. E., Filler, S. G., & Edwards, J. E. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02873.x · Cited by 218
“The incidence of candidaemia now surpasses the incidence of Escherichia coli bacteraemia (Edmond et al., 1999).”
BackgroundCarlisle, P. L., Banerjee, M., Lazzell, A., Monteagudo, C., López-Ribot, J. L., & Kadosh, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804061106 · Cited by 215
Beekmann, S. E., Diekema, D. J., Chapin, K. C., & Doern, G. V. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.7.3119-3125.2003 · Cited by 214
Jeu, L., Piacenti, F. J., Lyakhovetskiy, A. G., & Fung, H. B. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80126-1 · Cited by 213
Sahm, D. F., Marsilio, M. K., & Piazza, G. (1999) · Clinical Infectious Diseases · doi:10.1086/520195 · Cited by 213
Catheter-related infections: diagnosis and intravascular treatment
Bouza, E., Burillo, A., & Muñoz, P. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00385.x · Cited by 211
van Asbeck, E. C., Clemons, K. V., & Stevens, D. A. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903213393 · Cited by 210
Standaert–Vitse, A., Jouault, T., Vandewalle, P., Mille, C., Seddik, M., Sendid, B., Mallet, J., Colombel, J., & Poulain, D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.009 · Cited by 210
Blyth, C. C., Chen, S. C. A., Slavin, M. A., Serena, C., Nguyen, Q., Marriott, D., Ellis, D., Meyer, W., Sorrell, T. C., & Study, O. B. O. M. O. T. A. C. (2009) · Pediatrics · doi:10.1542/peds.2008-2055 · Cited by 206
Beekmann, S. E., Diekema, D. J., & Doern, G. V. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502584 · Cited by 206
Cappelletty, D., & Eiselstein‐McKitrick, K. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.369 · Cited by 205
Höffken, G., & Niederman, M. S. (2002) · Chest · doi:10.1378/chest.122.6.2183 · Cited by 205
Managing Antibiotic Resistance
Wenzel, R. P., & Edmond, M. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432610 · Cited by 204
Self-citationForeign body infections due to Staphylococcus epidermidis
Uçkay, I., Pittet, D., Vaudaux, P., Sax, H., Lew, D., & Waldvogel, F. (2009) · Annals of Medicine · doi:10.1080/07853890802337045 · Cited by 203
Wisplinghoff, H., Rosato, A. E., Enright, M. C., Noto, M., Craig, W., & Archer, G. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3574-3579.2003 · Cited by 203
Antifungal peptides: To be or not to be membrane active
Rautenbach, M., Troskie, A. M., & Vosloo, J. A. (2016) · Biochimie · doi:10.1016/j.biochi.2016.05.013 · Cited by 202
Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review
Bochud, P.-Y., Bonten, M., Marchetti, O., & Calandra, T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000143118.41100.14 · Cited by 201
Clark, T. A., Slavinski, S. A., Morgan, J., Lott, T., Arthington-Skaggs, B. A., Brandt, M. E., Webb, R. M., Currier, M., Flowers, R. H., Fridkin, S. K., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4468-4472.2004 · Cited by 200
Reed, S. D., Friedman, J. Y., Engemann, J. J., Griffiths, R. I., Anstrom, K. J., Kaye, K. S., Stryjewski, M. E., Szczech, L. A., Reller, L. B., Corey, G. R., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502523 · Cited by 200
Hazra, A., Dasgupta, S., Das, S., & Chawan, N. S. (2015) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.148633 · Cited by 196
Schlievert, P. M., Strandberg, K. L., Lin, Y.-C., Peterson, M. L., & Leung, D. Y. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.039 · Cited by 194
Trecarichi, E. M., Tumbarello, M., Spanu, T., Caira, M., Fianchi, L., Chiusolo, P., Fadda, G., Leone, G., Cauda, R., & Pagano, L. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.02.002 · Cited by 194
Multilocus Sequence Typing of Candidaglabrata Reveals Geographically EnrichedClades
Dodgson, A. R., Pujol, C., Denning, D. W., Soll, D. R., & Fox, A. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5709-5717.2003 · Cited by 190
Hyde, T. B., Hilger, T. M., Reingold, A., Farley, M. M., O’Brien, K. L., Schuchat, A., & for the Active Bacterial Core surveillance (ABCs) of the Emerging Infections Program Network (2002) · Pediatrics · doi:10.1542/peds.110.4.690 · Cited by 187
Engineering Sensor Arrays Using Aggregation‐Induced Emission Luminogens for Pathogen Identification
Zhou, C., Xu, W., Zhang, P., Jiang, M., Chen, Y., Kwok, R. T. K., Lee, M. M. S., Shan, G., Qi, R., Zhou, X., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201805986 · Cited by 185
Sandven, P. (2000) · PubMed · Cited by 185
McGregor, J. C., Kim, P. W., Perencevich, E. N., Bradham, D. D., Furuno, J. P., Kaye, K. S., Fink, J. C., Langenberg, P., Roghmann, M.-C., & Harris, A. D. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi068 · Cited by 184
Role of Hyphal Formation in Interactions of Candida albicans with Endothelial Cells
Phan, Q. T., Belanger, P. H., & Filler, S. G. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3485-3490.2000 · Cited by 181
Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy
Schinabeck, M. K., Long, L. A., Hossain, M. A., Chandra, J., Mukherjee, P. K., Mohamed, S., & Ghannoum, M. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1727-1732.2004 · Cited by 180
Nosocomial Bloodstream Infections: Organisms, Risk Factors, and Implications
Karchmer, A. W. (2000) · Clinical Infectious Diseases · doi:10.1086/314078 · Cited by 179
Krause, D. S., Reinhardt, J., Vazquez, J. A., Reboli, A., Goldstein, B. P., Wible, M., & Henkel, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2021-2024.2004 · Cited by 179
Perspectives for the management of febrile neutropenic patients with cancer in the 21st century
Sipsas, N. V., Bodey, G. P., & Kontoyiannis, D. P. (2005) · Cancer · doi:10.1002/cncr.20890 · Cited by 179
Arendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Jensen, I. M., Knudsen, J. D., Lundgren, B., Schønheyder, H. C., & Tvede, M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4434-4440.2005 · Cited by 178
Cornely, O. A., Bohme, A., Buchheidt, D., Einsele, H., Heinz, W. J., Karthaus, M., Krause, S. W., Kruger, W., Maschmeyer, G., Penack, O., et al. (2009) · Haematologica · doi:10.3324/haematol.11665 · Cited by 178
Candida auris: Disinfectants and Implications for Infection Control
Ku, T. S. N., Walraven, C. J., & Lee, S. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00726 · Cited by 177
“krusei are the Candida species that have been reported to cause over 95% of the cases of invasive candidiasis (Edmond et al., 1999; Wisplinghoff et al., 2004; Falagas et al., 2010; Pfaller et al., 2011; Andes et al., 2016; Strollo et al., 2016).”
BackgroundRinkinen, M., Jalava, K., Westermarck, E., Salminen, S., & Ouwehand, A. C. (2003) · Veterinary Microbiology · doi:10.1016/s0378-1135(02)00356-5 · Cited by 177
Active Surveillance of Candidemia, Australia
Chen, S., Slavin, M., Nguyen, Q., Marriott, D., Playford, E. G., Ellis, D., Sorrell, T., & Study, T. A. C. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1210.060389 · Cited by 174
Candida albicans, plasticity and pathogenesis
Poulain, D. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.813904 · Cited by 173
Advances in synthetic approach to and antifungal activity of triazoles
Shalini, K., Kumar, N., Drabu, S., & Sharma, P. K. (2011) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.7.79 · Cited by 173
Mailles, A., Blanckaert, K., Chaud, P., van der Werf, S., Lina, B., Caro, V., Campese, C., Guery, B. P., Prouvost, H., Lemaire, X., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.24.20502-en · Cited by 173
Antibiotic resistance of faecal enterococci in poultry, poultry farmers and poultry slaughterers
van den Bogaard, A. E. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.497 · Cited by 171
Virulence genes in the pathogenic yeast Candida albicans
Navarro-García, F., Sánchez, M., Nombela, C., & Pla, J. (2001) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2001.tb00577.x · Cited by 170
Coello, R., Charlett, A., Ward, V., Wilson, J., Pearson, A., Sedgwick, J., & Borriello, P. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1349 · Cited by 169
Treatment Options for Vancomycin- Resistant Enterococcal Infections
Linden, P. K. (2002) · Drugs · doi:10.2165/00003495-200262030-00002 · Cited by 169
Lin, M., Carmeli, Y., Zumsteg, J. M., Flores, E., Tolentino, J., Sreeramoju, P., & Weber, S. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4555-4560.2005 · Cited by 169
Khan, A., Khan, Azam, & Alam (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31219 · Cited by 167
Quorum sensing and Candida albicans
Kruppa, M. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01626.x · Cited by 130
Identification and Characterization of a Candida albicans Mating Pheromone
Bennett, R. J., Uhl, M. A., Miller, M. G., & Johnson, A. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8189-8201.2003 · Cited by 166
Sultana, R., McBain, A. J., & O'Neill, C. A. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00982-13 · Cited by 166
Vertebral Osteomyelitis due to Candida Species: Case Report and Literature Review
Miller, D. J., & Mejicano, G. C. (2001) · Clinical Infectious Diseases · doi:10.1086/322634 · Cited by 166
Nielsen, K., Cox, G. M., Litvintseva, A. P., Mylonakis, E. E., Malliaris, S. D., Benjamin, D. K., Giles, S. S., Mitchell, T. G., Casadevall, A., Perfect, J. R., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.4922-4933.2005 · Cited by 166
Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J., & Jones, R. N. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.78-83.2003 · Cited by 165
Self-citationMenzin, J., Meyers, J. L., Friedman, M., Perfect, J. R., Langston, A. A., Danna, R. P., & Papadopoulos, G. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080325 · Cited by 151
Candida Biofilms: Development, Architecture, and Resistance
Chandra, J., & Mukherjee, P. K. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0020-2015 · Cited by 164
Hsueh, P.-R., Chen, M.-L., Sun, C.-C., Chen, W.-H., Pan, H.-J., Yang, L.-S., Chang, S.-C., Ho, S.-W., Lee, C.-Y., Hsieh, W.-C., et al. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0801.000454 · Cited by 162
INFECTIOUS MORBIDITY IN CRITICALLY ILL PATIENTS WITH CANCER
Safdar, A., & Armstrong, D. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70198-6 · Cited by 161
Faria, N. A., Oliveira, D. C., Westh, H., Monnet, D. L., Larsen, A. R., Skov, R., & de Lencastre, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1836-1842.2005 · Cited by 160
Systemic candidiasis in intensive care units: A multicenter, matched-cohort study
Leleu, G., Aegerter, P., & Guidet, B. (2002) · Journal of Critical Care · doi:10.1053/jcrc.2002.35815 · Cited by 160
Wenzel, R. P., & Gennings, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430923 · Cited by 159
Self-citationPlayford, E. G., Webster, A. C., Sorrell, T. C., & Craig, J. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki491 · Cited by 159
Pierce, C. G., & Lopez-Ribot, J. L. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.807245 · Cited by 158
SENDID, B., POIROT, J. L., TABOURET, M., BONNIN, A., CAILLOT, D., CAMUS, D., & POULAIN, D. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-5-433 · Cited by 156
Surveillance of antibiotic resistance in European ICUs
Hanberger, H., Diekema, D. J., Fluit, A. C., Jones, R. N., Struelens, M. J., Spencer, R. C., & Wolff, M. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2001.0987 · Cited by 156
Self-citationStaphylococcus aureus bacteremia and endocarditis
Petti, C. A., & Fowler, V. G. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00030-4 · Cited by 155
Health Care–Associated Infections: Major Issues in the Early Years of the 21st Century
Wenzel, R. P. (2007) · Clinical Infectious Diseases · doi:10.1086/518136 · Cited by 154
Self-citationKofla, G., & Ruhnke, M. (2011) · European Journal of Medical Research · doi:10.1186/2047-783x-16-4-159 · Cited by 153
Grimont, F., & Grimont, P. A. D. (2006) · Springer eBooks · doi:10.1007/0-387-30746-x_9 · Cited by 152
Nobile, C. J., Solis, N., Myers, C. L., Fay, A. J., Deneault, J.-S., Nantel, A., Mitchell, A. P., & Filler, S. G. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01198.x · Cited by 150
“Distinct risk factors govern susceptibility to each type of infection (Edmond et al., 1999; Enoch et al., 2006).”
BackgroundGenome-Wide Transcription Profiling of the Early Phase of Biofilm Formation by Candida albicans
Murillo, L. A., Newport, G., Lan, C.-Y., Habelitz, S., Dungan, J., & Agabian, N. M. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.9.1562-1573.2005 · Cited by 150
Inflammatory Monocytes Mediate Early and Organ-Specific Innate Defense During Systemic Candidiasis
Ngo, L. Y., Kasahara, S., Kumasaka, D. K., Knoblaugh, S. E., Jhingran, A., & Hohl, T. M. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit413 · Cited by 150
Chen, S. C. ‐., Halliday, C. L., & Meyer, W. (2002) · Medical Mycology · doi:10.1080/mmy.40.4.333.357 · Cited by 149
González, G. M., Elizondo-Zertuche, M., & Ayala, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00937-08 · Cited by 149
Candida biofilm: a well-designed protected environment
Mukherjee, P. K., Zhou, G., Munyon, R., & Ghannoum, M. A. (2005) · Medical Mycology · doi:10.1080/13693780500107554 · Cited by 148
Eap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In Vivo
Li, F., Svarovsky, M. J., Karlsson, A. J., Wagner, J. P., Marchillo, K., Oshel, P., Andes, D., & Palecek, S. P. (2007) · Eukaryotic Cell · doi:10.1128/ec.00049-07 · Cited by 148
Hufnagel, M., Koch, S., Creti, R., Baldassarri, L., & Hüebner, J. (2004) · The Journal of Infectious Diseases · doi:10.1086/381150 · Cited by 147
Ren, D., Sims, J. J., & Wood, T. K. (2002) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2002.01087.x · Cited by 145
Shajahan, A., Culp, C. H., & Williamson, B. (2018) · Indoor Air · doi:10.1111/ina.12531 · Cited by 145
Recent advances in antifungal chemotherapy
Petrikkos, G. L., & Skiada, A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.03.009 · Cited by 145
Secular Trends of Candidemia Over 12 Years in Adult Patients at a Tertiary Care Hospital
GARBINO, J., KOLAROVA, L., ROHNER, P., LEW, D., PICHNA, P., & PITTET, D. (2002) · Medicine · doi:10.1097/00005792-200211000-00003 · Cited by 143
Phospholipase A2 and Phospholipase B activities in fungi
Köhler, G. A., Brenot, A., Haas-Stapleton, E. J., Agabian, N. M., Deva, R., & Nigam, S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.09.011 · Cited by 142
Prince, T., McBain, A. J., & O’Neill, C. A. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00595-12 · Cited by 142
Cuenca-Estrella, M., Rodriguez, D., Almirante, B., Morgan, J., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J., Gimenez, M., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh548 · Cited by 132
Alvarez, F. J., & Konopka, J. B. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-10-0931 · Cited by 140
Temporal analysis of Candida albicans gene expression during biofilm development
Yeater, K. M., Chandra, J., Cheng, G., Mukherjee, P. K., Zhao, X., Rodriguez-Zas, S. L., Kwast, K. E., Ghannoum, M. A., & Hoyer, L. L. (2007) · Microbiology · doi:10.1099/mic.0.2007/006163-0 · Cited by 140
Antoniadou, A., Torres, H. A., Lewis, R. E., Thornby, J., Bodey, G. P., Tarrand, J. P., Han, X.-Y., Rolston, K. V. I., Safdar, A., Raad, I. I., et al. (2003) · Medicine · doi:10.1097/01.md.0000091182.93122.8e · Cited by 131
Caspofungin: An echinocandin antifungal agent
Stone, E. A., Fung, H. B., & Kirschenbaum, H. L. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85039-1 · Cited by 139
Novel antifungal β-amino acids: synthesis and activity against Candida albicans
Mittendorf, J., Kunisch, F., Matzke, M., Militzer, H., Schmidt, A., & Schönfeld, W. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00958-7 · Cited by 138
Characterization of Plant-Derived Saponin Natural Products against Candida albicans
Coleman, J. J., Okoli, I., Tegos, G. P., Holson, E. B., Wagner, F. F., Hamblin, M. R., & Mylonakis, E. (2010) · ACS Chemical Biology · doi:10.1021/cb900243b · Cited by 137
Das, I., Nightingale, P., Patel, M., & Jumaa, P. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.06.006 · Cited by 137
The global epidemiology of invasive Candida infections—is the tide turning?
Hobson, R. P. (2003) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.08.012 · Cited by 137
Cornely, O. A., Ullmann, A. J., & Karthaus, M. (2003) · Blood · doi:10.1182/blood-2002-05-1356 · Cited by 137
Metadata
- Authors
- Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Wenzel, Richard P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 239-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157766752
- Cited by
- 1,387
- References
- 16
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 37 · 2018: 31 · 2017: 36 · 2016: 41 · 2015: 33 · 2014: 56 · 2013: 55 · 2012: 55
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial bloodstream infection, hospital-acquired bacteremia, coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus, Gram-positive bacteria, Gram-negative bacteria, fungemia, methicillin resistance, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, Streptococcus viridans, neutropenia, intensive care unit, empirical antibiotic therapy, infection surveillance
- MeSH terms
- Candida, Cross Infection, Gram-Negative Bacteria, Gram-Positive Bacteria, Hospitals, Humans, Neutropenia, Staphylococcus, United States, Fungemia, Bacteremia, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.